Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0387 Transporter Info
Gene Name	SLC4A7
Transporter Name	Sodium bicarbonate cotransporter 3
Gene ID	9497
UniProt ID	Q9Y6M7

Post-Translational Modification of This DT
Overview of SLC4A7 Modification Sites with Functional and Structural Information
Sequence	M E R F R L E K K L P G P D E E A V V D L G K T S S T V N T K F E K E E L E S H R A V Y I G V H V P F S K E S R R R H R H R G H K H H H R R R K D K E S D K E D G R E S P S Y D T P S Q R V Q F I L G T E D D D E E H I P H D L F T E M D E L C Y R D G E E Y E W K E T A R W L K F E E D V E D G G D R W S K P Y V A T L S L H S L F E L R S C I L N G T V M L D M R A S T L D E I A D M V L D N M I A S G Q L D E S I R E N V R E A L L K R H H H Q N E K R F T S R I P L V R S F A D I G K K H S D P H L L E R N G E G L S A S R H S L R T G L S A S N L S L R G E S P L S L L L G H L L P S S R A G T P A G S R C T T P V P T P Q N S P P S S P S I S R L T S R S S Q E S Q R Q A P E L L V S P A S D D I P T V V I H P P E E D L E A A L K G E E Q K N E E N V D L T P G I L A S P Q S A P G N L D N S K S G E I K G N G S G G S R E N S T V D F S K V D M N F M R K I P T G A E A S N V L V G E V D F L E R P I I A F V R L A P A V L L T G L T E V P V P T R F L F L L L G P A G K A P Q Y H E I G R S I A T L M T D E I F H D V A Y K A K D R N D L L S G I D E F L D Q V T V L P P G E W D P S I R I E P P K S V P S Q E K R K I P V F H N G S T P T L G E T P K E A A H H A G P E L Q R T G R L F G G L I L D I K R K A P F F L S D F K D A L S L Q C L A S I L F L Y C A C M S P V I T F G G L L G E A T E G R I S A I E S L F G A S L T G I A Y S L F A G Q P L T I L G S T G P V L V F E K I L Y K F C R D Y Q L S Y L S L R T S I G L W T S F L C I V L V A T D A S S L V C Y I T R F T E E A F A A L I C I I F I Y E A L E K L F D L G E T Y A F N M H N N L D K L T S Y S C V C T E P P N P S N E T L A Q W K K D N I T A H N I S W R N L T V S E C K K L R G V F L G S A C G H H G P Y I P D V L F W C V I L F F T T F F L S S F L K Q F K T K R Y F P T K V R S T I S D F A V F L T I V I M V T I D Y L V G V P S P K L H V P E K F E P T H P E R G W I I S P L G D N P W W T L L I A A I P A L L C T I L I F M D Q Q I T A V I I N R K E H K L K K G A G Y H L D L L M V G V M L G V C S V M G L P W F V A A T V L S I S H V N S L K V E S E C S A P G E Q P K F L G I R E Q R V T G L M I F I L M G L S V F M T S V L K F I P M P V L Y G V F L Y M G V S S L K G I Q L F D R I K L F G M P A K H Q P D L I Y L R Y V P L W K V H I F T V I Q L T C L V L L W V I K V S A A A V V F P M M V L A L V F V R K L M D L C F T K R E L S W L D D L M P E S K K K K E D D K K K K E K E E A E R M L Q D D D D T V H L P F E G G S L L Q I P V K A L K Y S P D K P V S V K I S F E D E P R K K Y V D A E T S L
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1144
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC4A7 Lysine 1144 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1151
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC4A7 Lysine 1151 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 171 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 269 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 398 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	406
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 406 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A7			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	776
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 776 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A7			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	786
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 786 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A7			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	791
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC4A7 Asparagine 791 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	993
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC4A7 Cystine 993 has the potential to affect its expression or activity.
Phosphorylation
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[6]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	1078
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Proline 1078 has the potential to affect its expression or activity.
Serine	48 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	25
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 25 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[7] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	26
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 26 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 39 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[9] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	52
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 52 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A7			[9] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	55
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 55 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A7			[9] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	76
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 76 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A7			[9] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 84 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC4A7			[9] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	86
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 86 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC4A7			[9] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	91
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 91 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC4A7			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	150
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 150 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC4A7			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 167 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC4A7			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	181
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 181 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	197
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 197 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 203 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC4A7			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 226 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC4A7			[9] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 233 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC4A7			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	242
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 242 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 260 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC4A7			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 266 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC4A7			[29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 268 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC4A7			[29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 271 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 297 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC4A7			[30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 309 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 317 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SLC4A7			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 382 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SLC4A7			[33] , [34]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	390
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 390 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SLC4A7			[23] , [35]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	392
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 392 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence SLC4A7			[9] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	400
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 400 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence SLC4A7			[9] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	403
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 403 has the potential to affect its expression or activity.
PTM Phenomenon 30	Have the potential to influence SLC4A7			[9] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	407
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 407 has the potential to affect its expression or activity.
PTM Phenomenon 31	Have the potential to influence SLC4A7			[16] , [36]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	412
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 412 has the potential to affect its expression or activity.
PTM Phenomenon 32	Have the potential to influence SLC4A7			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	429
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 429 has the potential to affect its expression or activity.
PTM Phenomenon 33	Have the potential to influence SLC4A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 487 has the potential to affect its expression or activity.
PTM Phenomenon 34	Have the potential to influence SLC4A7			[8] , [39]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	540
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 540 has the potential to affect its expression or activity.
PTM Phenomenon 35	Have the potential to influence SLC4A7			[9] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	556
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 556 has the potential to affect its expression or activity.
PTM Phenomenon 36	Have the potential to influence SLC4A7			[40]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	793
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 793 has the potential to affect its expression or activity.
PTM Phenomenon 37	Have the potential to influence SLC4A7			[40]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	840
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 840 has the potential to affect its expression or activity.
PTM Phenomenon 38	Have the potential to influence SLC4A7			[40]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	882
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 882 has the potential to affect its expression or activity.
PTM Phenomenon 39	Have the potential to influence SLC4A7			[41]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	966
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 966 has the potential to affect its expression or activity.
PTM Phenomenon 40	Have the potential to influence SLC4A7			[41]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	980
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 980 has the potential to affect its expression or activity.
PTM Phenomenon 41	Have the potential to influence SLC4A7			[41]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	982
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 982 has the potential to affect its expression or activity.
PTM Phenomenon 42	Have the potential to influence SLC4A7			[42]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1132
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1132 has the potential to affect its expression or activity.
PTM Phenomenon 43	Have the potential to influence SLC4A7			[42]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1141
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1141 has the potential to affect its expression or activity.
PTM Phenomenon 44	Have the potential to influence SLC4A7			[13] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1176 has the potential to affect its expression or activity.
PTM Phenomenon 45	Have the potential to influence SLC4A7			[7] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1188
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1188 has the potential to affect its expression or activity.
PTM Phenomenon 46	Have the potential to influence SLC4A7			[7] , [43]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1194
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1194 has the potential to affect its expression or activity.
PTM Phenomenon 47	Have the potential to influence SLC4A7			[29] , [44]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1198
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1198 has the potential to affect its expression or activity.
PTM Phenomenon 48	Have the potential to influence SLC4A7			[9] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1213
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Serine 1213 has the potential to affect its expression or activity.
Threonine	20 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[7] , [45]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	24
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 24 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[7] , [46]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	27
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 27 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 30 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[9] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	89
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 89 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 182 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A7			[9] , [23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	225
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 225 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A7			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 263 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC4A7			[9] , [25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	408
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 408 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	459
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 459 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC4A7			[38]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	490
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 490 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC4A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	493
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 493 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC4A7			[9] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	557
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 557 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC4A7			[9] , [47]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	559
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 559 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC4A7			[7] , [47]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	563
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 563 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC4A7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	663
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 663 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC4A7			[21] , [48]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	867
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 867 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC4A7			[48]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	873
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 873 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC4A7			[41]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	977
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 977 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC4A7			[13] , [47]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 1167 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC4A7			[7] , [49]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Threonine 1212 has the potential to affect its expression or activity.
Tyrosine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[50] , [51]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	44
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 44 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[9] , [16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 87 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[21] , [52]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	121
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 121 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[51] , [53]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	127
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 127 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A7			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	481
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 481 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A7			[37]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	502
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 502 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A7			[48]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	876
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 876 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC4A7			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1187
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 1187 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC4A7			[44] , [50]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1207
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC4A7 Tyrosine 1207 has the potential to affect its expression or activity.
Ubiquitination
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	776
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Asparagine 776 has the potential to affect its expression or activity.
Glutamicacid	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Glutamicacid 36 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	139
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Glutamicacid 139 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	495
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Glutamicacid 495 has the potential to affect its expression or activity.
Glycine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	146
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Glycine 146 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	1175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Glycine 1175 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	40
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Histidine 40 has the potential to affect its expression or activity.
Isoleucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	1058
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Isoleucine 1058 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[55]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	1088
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Isoleucine 1088 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	1134
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Leucine 1134 has the potential to affect its expression or activity.
Lysine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 23 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	31
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 31 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	34
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 34 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 130 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 137 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 503 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	539
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 539 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	546
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 546 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	548
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 548 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	590
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 590 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	784
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 784 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1066
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 1066 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1142
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 1142 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1183
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 1183 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1206
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Lysine 1206 has the potential to affect its expression or activity.
Phenylalanine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Phenylalanine 32 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	582
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Phenylalanine 582 has the potential to affect its expression or activity.
Proline	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	531
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Proline 531 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	538
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Proline 538 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[55]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	1203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Proline 1203 has the potential to affect its expression or activity.
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Serine 39 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	276
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Serine 276 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	540
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Serine 540 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1198
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Serine 1198 has the potential to affect its expression or activity.
Tryptophan	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	135
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Tryptophan 135 has the potential to affect its expression or activity.
Valine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Valine 28 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	43
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Valine 43 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC4A7			[54]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	142
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC4A7 Valine 142 has the potential to affect its expression or activity.

References
1	Co-trimoxazole induced aseptic meningitis. Arch Dis Child. 1995 Sep;73(3):257-8.
2	Overnight oscillations of rectal temperature. Arch Dis Child. 1995 Sep;73(3):277.
3	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S4A7_HUMAN)
4	Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86.
5	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
6	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
7	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
8	Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics. Front Cell Dev Biol. 2017 Nov 22;5:97.
9	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
10	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
11	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
12	Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci Signal. 2018 Aug 21;11(544):eaat6753.
13	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
14	Global Ion Suppression Limits the Potential of Mass Spectrometry Based Phosphoproteomics. J Proteome Res. 2019 Jan 4;18(1):493-507.
15	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
16	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
17	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
18	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
19	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
20	Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics. 2007 Dec;6(12):2072-87.
21	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
22	Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
23	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
24	Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
25	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
26	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
27	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
28	Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nat Commun. 2014 Sep 23;5:4961.
29	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
30	Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
31	Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
32	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
33	Dataset from the global phosphoproteomic mapping of early mitotic exit in human cells. Data Brief. 2015 Aug 24;5:45-52.
34	Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation Motifs. Mol Cell Proteomics. 2015 Aug;14(8):2194-212.
35	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
36	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
37	Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
38	Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis. 2010 Mar;31(6):1080-9.
39	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
40	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
41	Integrative network analysis of signaling in human CD34(+) hematopoietic progenitor cells by global phosphoproteomic profiling using TiO2 enrichment combined with 2D LC-MS/MS and pathway mapping. Proteomics. 2013 Apr;13(8):1325-33.
42	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
43	HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
44	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
45	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
46	Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells. Proteomics. 2017 Jun;17(11).
47	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
48	Single-step enrichment by Ti4+-IMAC and label-free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution. Mol Cell Proteomics. 2014 Sep;13(9):2426-34.
49	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
50	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
51	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
52	Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal. 2010 Aug 24;3(136):ra64.
53	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
54	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
55	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence